Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

Because of the expression of inhibitory receptors (KIR) for major histocompatibility complex (MHC) class I allotypes, a person's natural killer (NK) cells will not recognize and will, therefore, kill cells from individuals lacking his/her KIR epitopes. This study investigated the role of NK cell alloreactivity in human HLA haplotype-mismatched hematopoietic stem cell transplantation and, specifically, the role of the three major NK specificities, ie, those for HLA-C group 1, HLA-C group 2, and HLA-Bw4 alleles. In 20 of 60 donor-recipient pairs, KIR epitope incompatibility and functional analyses of donor NK cell clones predicted donor NK cells could cause graft-versus-host (GVH)/graft-versus-leukemia (GVL) reactions. NK cell clones of donor origin were obtained from transplanted recipients and tested for lysis of recipient's cryopreserved pretransplant lymphocytes. Despite the absence of GVH disease, we detected high frequencies of NK clones which killed recipient's target cells. Lysis followed the rules of NK cell alloreactivity, being blocked only by the MHC class I KIR epitope which was missing in the recipient. The alloreactive NK clones also killed the allogeneic leukemia. Transplants from these KIR epitope incompatible donors had higher engraftment rates. Therefore, a GVL effector and engraftment facilitating mechanism, which is independent of T-cell-mediated GVH reactions, may be operational in HLA mismatched hematopoietic cell transplants.

[1]  M. Martelli,et al.  Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.

[2]  D. Taub,et al.  Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. , 1998, The Journal of clinical investigation.

[3]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Ljunggren,et al.  Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I‐deficient mice , 1998, European journal of immunology.

[5]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[6]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[7]  L. Moretta,et al.  HLA class I specific inhibitory receptors. , 1997, Current opinion in immunology.

[8]  N. Schmitz,et al.  Allogeneic MHC‐mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft‐versus‐leukaemia effect in mice , 1997, British journal of haematology.

[9]  R. Biassoni,et al.  The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer , 1996, The Journal of experimental medicine.

[10]  B. Glass,et al.  Graft‐versus‐leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells , 1996, British journal of haematology.

[11]  A. Tosti,et al.  Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation. , 1996, Blood.

[12]  C. Verfaillie,et al.  Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture. , 1996, Blood.

[13]  A. Amoroso,et al.  Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Mcclanahan,et al.  Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.

[15]  P. Parham,et al.  Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones , 1995, The Journal of experimental medicine.

[16]  Eric O Long,et al.  Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.

[17]  M. Colonna,et al.  Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.

[18]  F. Aversa,et al.  Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. , 1994, Blood.

[19]  G. Ferrara,et al.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Szot,et al.  Hematopoietic cells and radioresistant host elements influence natural killer cell differentiation , 1993, The Journal of experimental medicine.

[21]  E. Brooks,et al.  Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. , 1993, Science.

[22]  A. Amoroso,et al.  Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) , 1992, The Journal of experimental medicine.

[23]  J. Strominger,et al.  Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Velardi,et al.  Adhesion molecule‐mediated signals regulate major histocompatibility complex‐unrestricted and CD3/T cell receptor‐triggered cytotoxicity , 1992, European journal of immunology.

[25]  J. Guardiola,et al.  Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans , 1992, The Journal of experimental medicine.

[26]  M. Colonna,et al.  Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Guardiola,et al.  Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells , 1990, The Journal of experimental medicine.

[28]  L. Barnett,et al.  Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. , 1990, Blood.

[29]  Eric O Long,et al.  Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture , 1988, The Journal of experimental medicine.

[30]  S. Jhanwar,et al.  Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation. , 1987, Blood.

[31]  L. Lanier.  NK cell receptors. , 1998, Annual review of immunology.

[32]  B. Glass,et al.  Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model. , 1993, Bone marrow transplantation.

[33]  M. Bennett,et al.  Murine natural killer cells and marrow graft rejection. , 1992, Annual review of immunology.